159 related articles for article (PubMed ID: 31011430)
1. Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait.
Abdullah AH; Holtorf AP; Al-Hussaini M; Lemay J; Alowayesh M; Kaló Z
J Pharm Policy Pract; 2019; 12():9. PubMed ID: 31011430
[TBL] [Abstract][Full Text] [Related]
2. Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia.
Inotai A; Brixner D; Maniadakis N; Dwiprahasto I; Kristin E; Prabowo A; Yasmina A; Priohutomo S; Németh B; Wijaya K; Kalo Z
BMC Health Serv Res; 2018 Dec; 18(1):1003. PubMed ID: 30594250
[TBL] [Abstract][Full Text] [Related]
3. Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE.
Farghaly MN; Al Dallal SAM; Fasseeh AN; Monsef NA; Suliman EAMA; Tahoun MA; Abaza S; Kaló Z
Front Pharmacol; 2021; 12():680737. PubMed ID: 34168564
[No Abstract] [Full Text] [Related]
4. A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt.
Elezbawy B; Fasseeh AN; Sedrak A; Eldessouki R; Gamal M; Eldebeiky M; Amer H; Akeel S; Morsy A; Amin A; Shafik A; Abaza S; Kaló Z
J Pharm Policy Pract; 2022 Mar; 15(1):10. PubMed ID: 35232487
[TBL] [Abstract][Full Text] [Related]
5. Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand.
Holtorf AP; Kristin E; Assamawakin A; Upakdee N; Indrianti R; Apinchonbancha N
J Pharm Policy Pract; 2021 Jun; 14(1):52. PubMed ID: 34127071
[TBL] [Abstract][Full Text] [Related]
6. Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets.
Brixner D; Maniadakis N; Kaló Z; Hu S; Shen J; Wijaya K
Value Health Reg Issues; 2017 Sep; 13():1-6. PubMed ID: 29073981
[TBL] [Abstract][Full Text] [Related]
7. A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt.
Elezbawy B; Fasseeh AN; Németh B; Gamal M; Eldebeiky M; Refaat R; Taha A; Rabiea S; Abdallah M; Ramadan S; Noaman H; Eldin AB; Mostafa H; Nouh S; Zaki A; Abdelrahman M; Abaza S; Kalò Z
BMC Med Inform Decis Mak; 2022 Nov; 22(1):289. PubMed ID: 36352382
[TBL] [Abstract][Full Text] [Related]
8. Shaping Pharmaceutical Tenders for Effectiveness and Sustainability in Countries with Expanding Healthcare Coverage.
Maniadakis N; Holtorf AP; Otávio Corrêa J; Gialama F; Wijaya K
Appl Health Econ Health Policy; 2018 Oct; 16(5):591-607. PubMed ID: 29987759
[TBL] [Abstract][Full Text] [Related]
9. [Multi-criteria decision analysis in clinical comprehensive evaluation of Chinese patent medicine].
Dai ZQ; Xu SM; Wu X; Li MM; Hu J; Liao X
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3155-3160. PubMed ID: 35851106
[TBL] [Abstract][Full Text] [Related]
10. Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA).
Rutten-van Mölken M; Leijten F; Hoedemakers M; Tsiachristas A; Verbeek N; Karimi M; Bal R; de Bont A; Islam K; Askildsen JE; Czypionka T; Kraus M; Huic M; Pitter JG; Vogt V; Stokes J; Baltaxe E;
BMC Health Serv Res; 2018 Jul; 18(1):576. PubMed ID: 30041653
[TBL] [Abstract][Full Text] [Related]
11. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
[TBL] [Abstract][Full Text] [Related]
12. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
[TBL] [Abstract][Full Text] [Related]
13. An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets.
Brixner D; Kaló Z; Maniadakis N; Kim K; Wijaya K
Value Health Reg Issues; 2018 Sep; 16():9-13. PubMed ID: 29605800
[TBL] [Abstract][Full Text] [Related]
14. Guidance toward the implementation of multicriteria decision analysis framework in developing countries.
Inotai A; Nguyen HT; Hidayat B; Nurgozhin T; Kiet PHT; Campbell JD; Németh B; Maniadakis N; Brixner D; Wijaya K; Kaló Z
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):585-592. PubMed ID: 30092151
[TBL] [Abstract][Full Text] [Related]
15. Developing a Multi-Criteria Decision Analysis Tool to Support the Adoption of Evidence-Based Child Maltreatment Prevention Programs.
Cruden G; Frerichs L; Powell BJ; Lanier P; Brown CH; Lich KH
Prev Sci; 2020 Nov; 21(8):1059-1064. PubMed ID: 33040271
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden.
Angelis A
MDM Policy Pract; 2018; 3(2):2381468318796218. PubMed ID: 35187241
[No Abstract] [Full Text] [Related]
17. Impact on decision making framework for medicine purchasing in Chinese public hospital decision-making: determining the value of five dipeptidyl peptidase 4 (DPP-4) inhibitors.
Bao Y; Gao B; Meng M; Ge B; Yang Y; Ding C; Shi B; Tian L
BMC Health Serv Res; 2021 Aug; 21(1):807. PubMed ID: 34384428
[TBL] [Abstract][Full Text] [Related]
18. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).
Wahlster P; Goetghebeur M; Kriza C; Niederländer C; Kolominsky-Rabas P;
BMC Health Serv Res; 2015 Jul; 15():262. PubMed ID: 26152122
[TBL] [Abstract][Full Text] [Related]
19. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
20. Multiple stakeholders in multi-criteria decision-making in the context of Municipal Solid Waste Management: A review.
Soltani A; Hewage K; Reza B; Sadiq R
Waste Manag; 2015 Jan; 35():318-28. PubMed ID: 25301545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
